Our 2025 Autumn Research Update Meeting will take place once again at the renowned Royal Society of Medicine (RSM), Wimpole Street, London, on Monday 10 November, where guests can look forward to an engaging agenda featuring the latest updates from our funded research.
Theme: Revolutionising Parkinson’s trial design with multi-arm, multi-stage (MAMS) trial platforms
Our next meeting will focus on multi-arm, multi-stage (MAMS) clinical trial platforms, an approach that is revolutionising Parkinson’s research by testing multiple treatments at once against a single placebo (dummy drug) group, speeding the development of new therapies. Attendees will hear presentations from two upcoming MAMS projects: EJS ACT-PD, a UK-based MAMS platform, and SLEIPNIR, a multi-arm clinical trial platform recently launched in Norway.
Agenda
2pm – Welcome and opening remarks
Helen Matthews, CEO, Cure Parkinson’s
2:05pm – Looking forward: Cure Parkinson’s Research Strategy +Q&A
Dr Simon Stott, Director of Research, Cure Parkinson’s
2:30pm – SLEIPNIR: A multi-arm platform for de-risking Parkinson’s treatments +Q&A
Prof Charalampos Tzoulis, University of Bergen
3:15pm – Tea and coffee break with a chance to learn more about clinical trial opportunities at our interactive information tables
3:45pm – International MAMS Consortium: Coordinating Parkinson’s trials worldwide
Dr Chirine Katrib, France Parkinson
4:00pm – EJS ACT-PD: how to get involved
Georgia Mills, Research Project Manager, UCL
4:30pm – Panel discussion: Participating In and Shaping Parkinson’s Research
Dr Kevin McFarthing and Michèle Bartlett, Co-Chairs of the EJS ACT-PD PPIE Working Group
Interviewer: Dr Simon Stott, Director of Research, Cure Parkinson’s
5pm – Closing remarks
5:05pm – Drinks reception
